Include EFIC as a partner in your research consortia/grant applications
Effective communication of results and societal/clinical impact are increasingly emphasised by research funding bodies. EFIC can help your research project achieve this and more through doing the following:
Choose EFIC as a secondment location for your Marie Curie fellowship
EFIC – as a non-academic organisation – provides a wonderful opportunity for young pain researchers to develop important transferable skills, and be exposed to activities, that are generally not a large part of the traditional academic environment. In particular, you have the opportunity to reach individuals in the non-academic sector, such as policy makers, politicians, clinicians, insurance companies and pain advocacy groups in Europe. In a 3-6 month secondment here, you will have to the opportunity to achieve the following:
Current Collaborations
Please find more information and updates on our current collaborations below.
ITPain – Improving Translational Research for Chronic Pain
ITPain is a one-year networking group project of 21 international experts funded by ERA-NET NEURON and aims to address the huge heterogeneity of protocol design and data collection in preclinical and clinical chronic pain trials, through harmonising protocol templates and data collection (including *omics-approaches) for preclinical and clinical trials and aligning them in a translational approach. This will be achieved by developing consensus on protocols and a minimum and clinically relevant “Core Set of Data”. Furthermore, a first step towards a joint server infrastructure for an enhanced comparability and analysis of already available data resources (collected by network members from previous studies to assess comparability and integrability of multidimensional datasets) and future trials is planned.
Disseminate and communicate the project results to multiple stakeholders including scientists, policymakers, and payers.
Frontier Research Competences for Neuro-modulation (FRESCO4NoPain)
FRESCO4NoPain is a 48-month EU-funded Marie Sklodowska-Curie Action, Doctoral Network that will provide world-class interdisciplinary training to 17 Doctoral Candidates in the area of non-pharmacological chronic pain treatment based on the pain-related brain oscillations and neuromodulation. The research will focus on three core areas: Preclinical Studies: Brain circuitries, oscillations, and neuromodulation in pain; Human Experimental Studies: Human mechanisms of brain oscillations and neuromodulation in pain; and Clinical Studies: Brain oscillations and neuromodulation in people with chronic pain.
EFIC is acting as a secondment location for Doctoral Candidates, where researchers will be able to develop a range of transferable skills through working directly for EFIC on its educational and scientific projects, as well as on advocacy, communication and general association management responsibilities.
Digi4MSK
Digi4MSK ‘Innovation Alliance for Musculoskeletal Health Literacy in the Digital Era’ is a three-year project funded under the European Erasmus+ programme and aims to develop musculoskeletal pain educational content and digital technology for training and educating health professionals and public.
Coordinate the development of guidelines for content; design structure of webinar series; design structure and unify teaching methodologies for workshops and pilot actions in the different European regions; supports all dissemination activities.
Comorbidity of cHronic Pain and mood disorders: breaking the vicious cYcle (HaPpY)
HaPpY is a Marie Skłodowska-Curie Innovative Training Network funded via the European Commission’s Horizon 2020 budget. HaPpY aims to create an optimal environment for the training of Early Stage Researchers (ESRs) to break the vicious cycle linking chronic pain and mood disorders. The final HAPpY event will be held in Cádiz for two full days, on the 25th and 26th of September 2025.
EFIC is acting as a host location for ESRs, where researchers will be able to develop a range of transferable skills through working directly for EFIC on its educational and scientific projects, as well as on advocacy, communication and general association management responsibilities.
Value of Treatment – Chronic Pain
The Value of Treatment project is managed by the European Brain Council with financial support from Grunenthal and Pfizer. The project aims to develop a robust health economic assessment of multimodal chronic pain treatment, with input from patients, researchers and clinicians. The project aims to identify the ideal care pathways for various pain types and the socioeconomic impacts of adequate treatment.
EFIC nominated experts to participate in the project, including the current project lead, Professor Rolf-Detlef Treede. EFIC experts provide advice on the project methodology and the EFIC team will eventually support communication and dissemination via advocacy activities.
ECHOO (Empowering European Health Consumers through Higher Education on PlacebO and NocebO Effects)
ECHOO aims to address key gaps in understanding placebo and nocebo effects by providing evidence-based knowledge and competencies for health consumers, supporting improved health self-management.
EFIC will collaborate with institutions across Europe to support the project’s scientific activities and dissemination over the next three years.
IN-ChildPain: The International Network on Chronic Pain in Childhood
IN-ChildPain is a one-year networking group project of 24 international experts funded by ERA-NET NEURON and aims to identify the most important outcome domains that should be assessed in paediatric pain clinical trials and identify the most appropriate (i.e., psychometrically robust, available to researchers at no cost, and easy to translate into multiple languages) patient reported outcome measures (PROMs), develop a guide for an international registry of children with chronic pain and develop a research protocol to study the availability of, and access to, different treatments, to help evaluate their effects as naturally provided to patients.
Assist with developing a plan for sustaining the existence of In-ChildPain beyond the life of the action, and particularly in the dissemination and communication to multiple stakeholders including scientists, policymakers, and payers.
Past Collaborations
Please find more information on past collaborations below.
PANACEA
PANACEA is a three-year project funded under the European Erasmus+ programme and aims to contribute to reducing the gap between placebo/nocebo scientific evidence and clinical practice of the future, i.e., higher education students in medicine and nursing, and of today healthcare professionals.
EFIC will be responsible for 1. collecting information from clinical practice experience, 2. organizing a symposium where experts can share their expertise and opinions about the management of placebo and nocebo effect in clinical practice, and 3. supervising the planning of the main dissemination events.
PAIN OUT
Project details to be added.
INTERACT-EUROPE
INTERACT-EUROPE is a large multistakeholder project bringing together 33 partners from 17 countries. It aims to develop a European inter-specialty cancer training programme involving all main oncology disciplines and professions, cancer centres and patient groups, based on relevant needs assessments. It is co-funded by the EU under the EU4Health programme 2021-2027, as part of Europe’s Beating Cancer Plan.
EFIC’s key role is communication and dissemination. EFIC will provide strategic communication advice and lead on content development including webinars, lay summaries, infographics, and newsletters. This will ensure the project results are communicated to the wider scientific community, general public, and policymakers.
smartCARE
smartCARE: Improving Cancer Survivors’ Quality of Life is a 24-month project funded under the EU4Health programme 2021-2027 which brings together 41 partners. It aims to develop a ‘Cancer Survivor Smart Card’ – in the form of a mobile application – to improve the quality of life and health status of cancer survivors.
EFIC is a consultative partner on the project and our main role is to provide scientific input on the user needs and advise on the piloting stages.
IMI-Pain Care
IMI-PainCare is a large multi-stakeholder consortium funded via the Innovative Medicines Initiative 2 programme, which receives funding from the European Commission and the pharmaceutical industry. IMI-PainCare aims to develop alignment on patient reported outcomes used in pain research, identification of biomarkers for pain, and the refinement of preclinical models for improved translational pain research. Find out more about the project here.
EFIC is one of three scientific societies contributing to the project. EFIC leads on communication activities, disseminating the results of the project to the wider scientific community and general public, providing strategic communication advice and leading on content development such as webinars and lay summaries. Download the 2022 IMI-PainCare infographic.
Marie Skłodowska-Curie Fellowship – Mary O’Keeffe
Project details to be added.
EIT Health Wild Card 2021 Pain Management call
EIT Health is a public private partnership funded via the European Commission, bringing together scientists, entrepreneurs, engineers, clinicians and others to foster innovative research and business proposals based on new technologies. The Wildcard programme establishes multidisciplinary teams who are asked to develop a project between them, pitch it to experts and, if chosen, develop a business plan and eventually launch with start-up funding. In 2021 Pain Management was chosen as one of two topics.
EFIC have helped promote the call to the pain research community via communication activities, identify experts for the applicant review process, and to identify mentors and lecturers for those chosen.
- 15 Oct 2021EIT Health Wild Card 2021: project update